Search results
Results From The WOW.Com Content Network
Shareholders will receive one common share of Grail for every six shares of Illumina, which will retain a 14.5% stake in the unit after the spinoff on June 24. Shares of Illumina were up 4% in ...
The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in ...
(Reuters) -A U.S. appeals court on Friday struck down a Federal Trade Commission order against Illumina's purchase of cancer diagnostic test maker Grail, a former subsidiary, saying the agency had ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and ...
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California.It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. [3]
Anthony William Czarnik (born 1957) is an American chemist and inventor.He is best known for pioneering studies in the field of fluorescent chemosensors [6] [7] [2] [8] and co-founding Illumina, Inc., a biotechnology company in San Diego.
Illumina, which founded Grail and spun it off in 2016 only to re-acquire it in 2021 for $7.1 billion, had fought against the European Commission's decision to wield a rarely-used power called ...
The EU competition enforcer subsequently blocked the $7.1 billion deal in 2022 on concerns that Illumina would have an incentive to stop Grail's rivals from accessing its technology to develop ...